{
  "id": 1731606,
  "title": "This gene-based therapeutics stock could nearly triple, analysts say",
  "url": "https://urgent.news/2026/08/18/this-gene-based-therapeutics-stock-could-nearly-triple-analysts-say",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-18T14:18:17.000Z",
  "source": {
    "name": "CNBC",
    "slug": "cnbc",
    "url": "https://www.cnbc.com/2026/08/18/this-gene-editing-stock-could-nearly-triple-its-shares-analysts-say.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Three firms initiated coverage of the the gene-based therapeutics company.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "CNBC World",
        "title": "This gene-based therapeutics stock could nearly triple, analysts say",
        "url": "https://urgent.news/2026/08/18/this-gene-based-therapeutics-stock-could-nearly-triple-analysts-say-1744498",
        "published": "2026-08-18T14:18:17.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}